| ID | 1552 |
|---|
| No | 1552 |
|---|
| Brand Name | TREVIA TABLETS 50 MG |
|---|
| Ingredients | SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG |
|---|
| Dosage Form | FILM-COATED TABLETS |
|---|
| Primary Packaging | ALU-ALU |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 5 X 7'S AND BOX OF 2 X 7'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREVIA ( SITAGLIPTIN) IS INDICATED IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | PEACH ORANGE COLORED, ROUND SHAPED BICONVEX, FILM - COATED TABLETS PLAIN ON BOTH SIDES. |
|---|
| Note | |
|---|
| License Owner | LAO INTER PHARMA CO.,LTD |
|---|
| Manufacturer | GETZ PHARMA (PRIVATE) LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 I 4113/15 |
|---|
| FDD Registration Date | 10/02/2023 |
|---|
| Expiry Date | 09/02/2026 |
|---|
